Acute Montelukast in Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

August 31, 2004

Study Completion Date

October 31, 2004

Conditions
Acute Asthma Exacerbation
Interventions
DRUG

Montelukast

1 study capsule at study entry Montelukast 10mg and a further study capsule at 10pm for four weeks

DRUG

Placebo

1 placebo capsule at study entry and a further placebo capsule at 10pm for four weeks

Trial Locations (1)

NR47UY

Norfolk and Norwich University Hospital, Norwich

All Listed Sponsors
collaborator

Norfolk Association of Asthma Nurses

UNKNOWN

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of East Anglia

OTHER

NCT01011452 - Acute Montelukast in Asthma | Biotech Hunter | Biotech Hunter